Establishment Labs [ESTA] vs Boston Scientific [BSX] Detailed Stock Comparison

TLDR: Quick Comparison Summary

Based on 19 vital metrics comparison: Establishment Labs wins in 5 metrics, Boston Scientific wins in 13 metrics, with 0 ties. Boston Scientific appears stronger overall.

View Metrics Details

Vital Metrics Comparison

MetricEstablishment LabsBoston ScientificBetter
P/E Ratio (TTM)-14.5562.79Establishment Labs
Price-to-Book Ratio50.896.97Boston Scientific
Debt-to-Equity Ratio993.3453.09Boston Scientific
PEG Ratio1.800.43Boston Scientific
EV/EBITDA-24.6235.89Establishment Labs
Profit Margin (TTM)-49.89%13.55%Boston Scientific
Operating Margin (TTM)-27.50%18.63%Boston Scientific
EBITDA Margin (TTM)N/A18.63%N/A
Return on Equity-261.18%11.55%Boston Scientific
Return on Assets (TTM)-12.78%5.39%Boston Scientific
Free Cash Flow (TTM)$-74.08M$2.37BBoston Scientific
1-Year Return-4.40%34.10%Boston Scientific
Price-to-Sales Ratio (TTM)6.538.45Establishment Labs
Enterprise Value$1.33B$168.87BBoston Scientific
EV/Revenue Ratio7.509.13Establishment Labs
Gross Profit Margin (TTM)68.76%67.65%Establishment Labs
Revenue per Share (TTM)$6$13Boston Scientific
Earnings per Share (Diluted)$-3.08$1.68Boston Scientific
Beta (Stock Volatility)0.830.66Boston Scientific
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends

Establishment Labs vs Boston Scientific Stock Performance Analysis

Loading Price Chart...

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Establishment Labs9.10%13.88%0.39%18.43%23.94%-3.62%
Boston Scientific0.91%2.91%2.92%1.60%1.71%18.78%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Establishment Labs-4.40%-33.19%147.95%65.37%65.37%65.37%
Boston Scientific34.10%162.02%158.76%521.97%1,833.88%304.77%

Performance & Financial Health Analysis: Establishment Labs vs Boston Scientific

MetricESTABSX
Market Information
Market Cap i$1.16B$156.30B
Market Cap CategorySmall capLarge cap
10 Day Avg. Volume i543,5405,419,170
90 Day Avg. Volume i416,2506,881,810
Last Close$43.64$106.17
52 Week Range$26.56 - $50.85$78.53 - $108.94
% from 52W High-14.18%-2.54%
All-Time High$93.80 (Apr 18, 2022)$108.94 (Jul 23, 2025)
% from All-Time High-53.48%-2.54%
Growth Metrics
Quarterly Revenue Growth0.16%0.23%
Quarterly Earnings Growth0.16%1.46%
Financial Health
Profit Margin (TTM) i-0.50%0.14%
Operating Margin (TTM) i-0.28%0.19%
Return on Equity (TTM) i-2.61%0.12%
Debt to Equity (MRQ) i993.3453.09
Cash & Liquidity
Book Value per Share (MRQ)$0.79$15.14
Cash per Share (MRQ)$1.89$0.36
Operating Cash Flow (TTM) i$-72,688,000$4.28B
Levered Free Cash Flow (TTM) i$-39,815,124$2.94B
Dividends
Last 12-Month Dividend Yield iN/AN/A
Last 12-Month Dividend iN/AN/A

Valuation & Enterprise Metrics Analysis: Establishment Labs vs Boston Scientific

MetricESTABSX
Price Ratios
P/E Ratio (TTM) i-14.5562.79
Forward P/E i-24.2437.81
PEG Ratio i1.800.43
Price to Sales (TTM) i6.538.45
Price to Book (MRQ) i50.896.97
Market Capitalization
Market Capitalization i$1.16B$156.30B
Enterprise Value i$1.33B$168.87B
Enterprise Value Metrics
Enterprise to Revenue i7.509.13
Enterprise to EBITDA i-24.6235.89
Risk & Other Metrics
Beta i0.830.66
Book Value per Share (MRQ) i$0.79$15.14

Financial Statements Comparison: Establishment Labs vs Boston Scientific

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)ESTABSX
Revenue/Sales i$51.30M$4.66B
Cost of Goods Sold i$16.03M$1.45B
Gross Profit i$35.27M$3.21B
Research & Development i$5.20M$443.00M
Operating Income (EBIT) i$-14.11M$937.00M
EBITDA i$-7.04M$1.23B
Pre-Tax Income i$-15.59M$805.00M
Income Tax i$1.00M$133.00M
Net Income (Profit) i$-16.59M$672.00M

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)ESTABSX
Cash & Equivalents i$69.18M$725.00M
Total Current Assets i$231.70M$7.34B
Total Current Liabilities i$69.04M$5.06B
Long-Term Debt i$224.14M$10.93B
Total Shareholders Equity i$38.55M$22.45B
Retained Earnings i$-465.40M$3.35B
Property, Plant & Equipment i$5.19M$448.00M

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)ESTABSX
Operating Cash Flow i$-24.24M$513.00M
Capital Expenditures i$-753,000$-187.00M
Free Cash Flow i$-21.75M$277.00M
Debt Repayment iN/A$-1.31B
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricESTABSX
Shares Short i4.76M16.27M
Short Ratio i14.572.15
Short % of Float i0.24%0.01%
Average Daily Volume (10 Day) i543,5405,419,170
Average Daily Volume (90 Day) i416,2506,881,810
Shares Outstanding i28.79M1.47B
Float Shares i16.95M1.48B
% Held by Insiders i0.11%0.00%
% Held by Institutions i1.05%0.94%

Dividend Analysis & Yield Comparison: Establishment Labs vs Boston Scientific

MetricESTABSX
Last 12-Month Dividend iN/AN/A
Last 12-Month Dividend Yield iN/AN/A
3-Year Avg Annual Dividend iN/AN/A
3-Year Avg Dividend Yield iN/AN/A
3-Year Total Dividends iN/AN/A
Ex-Dividend DateN/AN/A